Evidence-based health care in pediatrics

Suzanne Robertson-Malt1

  • 1Implementation Science, Joanna Briggs Institute, School of Translational Health Science, University of Adelaide, 1/115 Grenfell Street, Adelaide, South Australia 5000, Australia.

Insights

This study reviews the quality of systematic evidence for pediatric healthcare. It highlights standards for conducting, publishing, and implementing these reviews into clinical practice.

Area of Science:

  • Pediatric Health Research
  • Evidence-Based Medicine
  • Systematic Review Methodology

Background:

  • The evidence base for pediatric healthcare relies heavily on systematic reviews.
  • Assessing the quality and trends of these reviews is crucial for improving child health outcomes.
  • Translating research findings into clinical practice remains a significant challenge.

Purpose of the Study:

  • To examine current trends in the type and quality of systematic reviews in pediatric healthcare.
  • To highlight quality standards for the conduct and publication of systematic reviews.
  • To explore processes for integrating systematic review evidence into pediatric care.

Main Methods:

  • A case study approach was employed.
  • Analysis of systematic review quality standards.
  • Examination of evidence-to-practice transition strategies.

Main Results:

  • Identified trends in systematic review quality for pediatric health.
  • Highlighted key standards for systematic review conduct and publication.
  • Showcased methods for implementing evidence into pediatric care systems.

Conclusions:

  • Improving the quality and accessibility of systematic reviews is essential for advancing pediatric healthcare.
  • Effective strategies are needed to bridge the gap between research evidence and clinical practice.
  • Adherence to rigorous standards ensures the reliability of evidence used in child health decisions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
392
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
935